Literature DB >> 30970248

Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects.

Alex R D Delbridge1, Andrew J Kueh1, Francine Ke1, Natasha M Zamudio2, Farrah El-Saafin1, Natasha Jansz1, Gao-Yuan Wang3, Megan Iminitoff2, Tamara Beck2, Sue Haupt4, Yifang Hu2, Rose E May2, Lachlan Whitehead1, Lin Tai2, William Chiang1, Marco J Herold1, Ygal Haupt5, Gordon K Smyth6, Tim Thomas1, Marnie E Blewitt7, Andreas Strasser8, Anne K Voss9.   

Abstract

Neural tube defects (NTDs) are common birth defects in humans and show an unexplained female bias. Female mice lacking the tumor suppressor p53 display NTDs with incomplete penetrance. We found that the combined loss of pro-apoptotic BIM and p53 caused 100% penetrant, female-exclusive NTDs, which allowed us to investigate the female-specific functions of p53. We report that female p53-/- embryonic neural tube samples show fewer cells with inactive X chromosome markers Xist and H3K27me3 and a concomitant increase in biallelic expression of the X-linked genes, Huwe1 and Usp9x. Decreased Xist and increased X-linked gene expression was confirmed by RNA sequencing. Moreover, we found that p53 directly bound response elements in the X chromosome inactivation center (XIC). Together, these findings suggest p53 directly activates XIC genes, without which there is stochastic failure in X chromosome inactivation, and that X chromosome inactivation failure may underlie the female bias in neural tube closure defects.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BCL2L11; BIM; Ftx; SMCHD1; Tsix; X-chromosome inactivation; Xist; biallelic expression; female-specific neural tube defects; p53

Mesh:

Substances:

Year:  2019        PMID: 30970248     DOI: 10.1016/j.celrep.2019.03.048

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  18 in total

Review 1.  Sex disparities matter in cancer development and therapy.

Authors:  Sue Haupt; Franco Caramia; Sabra L Klein; Joshua B Rubin; Ygal Haupt
Journal:  Nat Rev Cancer       Date:  2021-04-20       Impact factor: 60.716

Review 2.  The search for genetic determinants of human neural tube defects.

Authors:  Paul Wolujewicz; M Elizabeth Ross
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

Review 3.  The spectrum of sex differences in cancer.

Authors:  Joshua B Rubin
Journal:  Trends Cancer       Date:  2022-02-18

Review 4.  X chromosome agents of sexual differentiation.

Authors:  Arthur P Arnold
Journal:  Nat Rev Endocrinol       Date:  2022-06-15       Impact factor: 47.564

5.  Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.

Authors:  Amar H Mahdi; Yanying Huo; Ying Chen; Pier Selenica; Anchal Sharma; Elise Merritt; Nicola Barnard; Chang Chan; Shridar Ganesan; Jorge S Reis-Filho; Britta Weigelt; Subhajyoti De; Bing Xia
Journal:  Genes Dis       Date:  2020-09-05

6.  Long non-coding RNA exploration for mesenchymal stem cell characterisation.

Authors:  Sébastien Riquier; Marc Mathieu; Chloé Bessiere; Anthony Boureux; Florence Ruffle; Jean-Marc Lemaitre; Farida Djouad; Nicolas Gilbert; Thérèse Commes
Journal:  BMC Genomics       Date:  2021-06-04       Impact factor: 3.969

Review 7.  Sexual Differentiation Specifies Cellular Responses to DNA Damage.

Authors:  Lauren Broestl; Joshua B Rubin
Journal:  Endocrinology       Date:  2021-11-01       Impact factor: 5.051

8.  Puma- and Caspase9-mediated apoptosis is dispensable for p53-driven neural crest-based developmental defects.

Authors:  Margot E Bowen; Abigail S Mulligan; Aryo Sorayya; Laura D Attardi
Journal:  Cell Death Differ       Date:  2021-02-11       Impact factor: 12.067

9.  Sex- and mutation-specific p53 gain-of-function activity in gliomagenesis.

Authors:  Nathan C Rockwell; Wei Yang; Nicole M Warrington; Max V Staller; Malachi Griffith; Obi L Griffith; Christina A Gurnett; Barak A Cohen; Dustin Baldridge; Joshua B Rubin
Journal:  Cancer Res Commun       Date:  2021-12

10.  p53 convergently activates Dux/DUX4 in embryonic stem cells and in facioscapulohumeral muscular dystrophy cell models.

Authors:  Bradley D Weaver; Christina M Smith; Edward J Grow; Jingtao Guo; Paula Stein; Sean C Shadle; Peter G Hendrickson; Nicholas E Johnson; Russell J Butterfield; Roberta Menafra; Susan L Kloet; Silvère M van der Maarel; Carmen J Williams; Bradley R Cairns
Journal:  Nat Genet       Date:  2021-07-15       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.